touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 2

touchPODCAST

touchMDT for touchONCOLOGY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team

• Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
• Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
• Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
• Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
• Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany

This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:

www.touchONCOLOGY.com